SARTORIUS (SARTF) Stock Price, News & Analysis

Company Overview

Sartorius AG, trading as SARTF on the OTCMKTS, is a leading international supplier of laboratory and bioprocessing equipment for the life sciences sector. Founded in 1870 in Göttingen, Germany, the company has evolved from a manufacturer of precision weighing scales into a diversified provider of products and services that support research and production in the biopharmaceutical industry.

The company operates through two main business divisions. The Bioprocess Solutions segment offers technologies for the filtration, fermentation and purification of biological drugs, including single-use bioreactors, chromatography systems and membrane filtration devices. The Lab Products & Services unit supplies laboratory instruments such as analytical balances, pipettes, cell counters and consumables, alongside software and services that enhance workflow efficiency and data integrity in research laboratories.

Sartorius maintains a global network of research and manufacturing facilities across Europe, North America, Asia and Latin America. Its products are used by pharmaceutical and biotech companies, academic research institutes and contract development and manufacturing organizations (CDMOs). The company emphasizes close collaboration with customers to tailor solutions for process scale-up, quality control and regulatory compliance.

Under the leadership of a seasoned executive board headed by chief executive officer Dr. Joachim Kreuzburg, Sartorius continues to invest in innovation, digitalization and sustainability initiatives. The company focuses on expanding its single-use technology portfolio and enhancing automation capabilities to meet growing demand for biologics and advanced therapies worldwide.

Key Stats

• Today's Range: $208.82 to $208.82
• 50-Day Range: $187.82 to $210.47
• 52-Week Range: $165.00 to $243.35
• Volume: N/A
• Average Volume: 4 shs
• Market Capitalization: N/A
• P/E Ratio: 141.09
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

SARTF Stock Analysis - Frequently Asked Questions

How have SARTF shares performed this year?

SARTORIUS's stock was trading at $184.00 on January 1st, 2025. Since then, SARTF shares have increased by 13.5% and is now trading at $208.8150.

How were SARTORIUS's earnings last quarter?

SARTORIUS (OTCMKTS:SARTF) issued its quarterly earnings results on Wednesday, April, 16th. The company reported $1.28 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.28. The company had revenue of $959.23 million for the quarter, compared to analysts' expectations of $867.08 million. SARTORIUS had a trailing twelve-month return on equity of 7.62% and a net margin of 2.76%.

Does SARTORIUS have any subsidiaries?

SARTORIUS subsidiaries include these companies: Novasep’s chromatography division, ALS Automated Lab Solutions GmbH, Xell AG, CellGenix Inc., WaterSep BioSeparations LLC, BIA Separations, Biological Industries, and more.

How do I buy shares of SARTORIUS?

Shares of SARTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 4/16/2025
• Today: 7/12/2025
• Next Earnings (Estimated): 7/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SARTF
• Previous Symbol: NASDAQ:SARTF
• CIK: N/A
• Web: www.sartorius.com
• Phone: 495513080
• Fax: 49-55-1308-3289
• Employees: 13,528
• Year Founded: 1870

Profitability

• EPS (Trailing Twelve Months): $1.48
• Trailing P/E Ratio: 141.09
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $90.90 million
• Net Margins: 2.76%
• Pretax Margin: 6.16%
• Return on Equity: 7.62%
• Return on Assets: 2.92%

Debt

• Debt-to-Equity Ratio: 1.09
• Current Ratio: 1.46
• Quick Ratio: 0.93

Sales & Book Value

• Annual Sales: $3.66 billion
• Price / Sales: N/A
• Cash Flow: $29.00 per share
• Price / Cash Flow: 7.20
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 1.07